Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-01-19 Sale |
2021-01-21 4:15 pm |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
25,000 | $49.47 | $1,236,719 | 74,425 (Direct) |
View |
2020-12-28 Sale |
2020-12-30 4:15 pm |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
25,000 | $51.45 | $1,286,157 | 99,425 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-01-19 Exercise |
2021-01-21 4:15 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
25,000 | $0.41 | 74,425 (Direct) |
View |
2021-01-19 Exercise |
2021-01-21 4:15 pm |
N/A 2027-08-23 |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
25,000 | $0 | 74,425 (Direct) |
View |
2020-12-28 Exercise |
2020-12-30 4:15 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
25,000 | $0.41 | 99,425 (Direct) |
View |
2020-12-28 Exercise |
2020-12-30 4:15 pm |
N/A 2027-08-23 |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
25,000 | $0 | 99,425 (Direct) |
View |
2020-06-22 Option Award |
2020-06-23 5:55 pm |
N/A 2030-06-21 |
BioXcel Therapeutics Inc. | BTAI | Benabou Reina See Remarks |
60,000 | $0 | 60,000 (Direct) |
View |
2020-06-15 Option Award |
2020-06-17 4:14 pm |
N/A 2030-06-14 |
BioXcel Therapeutics Inc. | BTAI | Kane William P Jr Chief Commercial Officer |
110,000 | $0 | 110,000 (Direct) |
View |
2020-05-26 Option Award |
2020-05-28 4:16 pm |
N/A 2030-05-25 |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
45,000 | $0 | 45,000 (Direct) |
View |
2020-05-26 Option Award |
2020-05-28 4:16 pm |
N/A 2030-05-25 |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
55,000 | $0 | 55,000 (Direct) |
View |
2020-05-26 Option Award |
2020-05-28 4:15 pm |
N/A 2030-05-25 |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO, President and Secretary 10% Owner |
250,000 | $0 | 250,000 (Direct) |
View |
2020-05-26 Option Award |
2020-05-28 4:15 pm |
N/A 2030-05-25 |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
40,000 | $0 | 40,000 (Direct) |
View |
2020-05-21 Option Award |
2020-05-26 4:17 pm |
N/A 2030-05-21 |
BioXcel Therapeutics Inc. | BTAI | Laumas Sandeep Director |
20,000 | $0 | 20,000 (Direct) |
View |
2020-05-21 Option Award |
2020-05-26 4:17 pm |
N/A 2030-05-21 |
BioXcel Therapeutics Inc. | BTAI | MUELLER PETER Director |
25,000 | $0 | 25,000 (Direct) |
View |
2020-05-21 Other |
2020-05-26 4:17 pm |
N/A 2030-05-21 |
BioXcel Therapeutics Inc. | BTAI | Votruba Michal Director |
20,000 | $0 | 20,000 (Direct) |
View |
2020-05-21 Option Award |
2020-05-26 4:17 pm |
N/A 2030-05-21 |
BioXcel Therapeutics Inc. | BTAI | Votruba Michal Director |
20,000 | $0 | 20,000 (Direct) |
View |